Image 2_Altered gut microbiome in convalescent patients with coronavirus disease 2019.tif by Kyoung Hwa Lee (8906261)

“…This study aimed to assess the association between the disease severity of COVID-19 and changes in stool microbes through a seven-month follow-up of stool collection.</p>Methods<p>We conducted a multicentre, prospective longitudinal study of 58 COVID-19 patients and 116 uninfected controls. …”

Image 1_Altered gut microbiome in convalescent patients with coronavirus disease 2019.tif by Kyoung Hwa Lee (8906261)

“…This study aimed to assess the association between the disease severity of COVID-19 and changes in stool microbes through a seven-month follow-up of stool collection.</p>Methods<p>We conducted a multicentre, prospective longitudinal study of 58 COVID-19 patients and 116 uninfected controls. …”

Data_Sheet_2_vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections.pdf by Yalu Ji (6741050)

“…Due to the ability of phages to kill multidrug-resistant bacteria, the use of phage therapy to combat multidrug-resistant bacterial infections has attracted attention. In this study, a T. pyogenes phage, vB-ApyS-JF1 (JF1), was isolated from sewage samples, and its whole genome and biological characteristics were elucidated. …”

Data_Sheet_1_vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections.docx by Yalu Ji (6741050)

“…Due to the ability of phages to kill multidrug-resistant bacteria, the use of phage therapy to combat multidrug-resistant bacterial infections has attracted attention. In this study, a T. pyogenes phage, vB-ApyS-JF1 (JF1), was isolated from sewage samples, and its whole genome and biological characteristics were elucidated. …”

Data_Sheet_1_vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections.docx by Yalu Ji (6741050)

“…Due to the ability of phages to kill multidrug-resistant bacteria, the use of phage therapy to combat multidrug-resistant bacterial infections has attracted attention. In this study, a T. pyogenes phage, vB-ApyS-JF1 (JF1), was isolated from sewage samples, and its whole genome and biological characteristics were elucidated. …”

Data_Sheet_2_vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections.pdf by Yalu Ji (6741050)

“…Due to the ability of phages to kill multidrug-resistant bacteria, the use of phage therapy to combat multidrug-resistant bacterial infections has attracted attention. In this study, a T. pyogenes phage, vB-ApyS-JF1 (JF1), was isolated from sewage samples, and its whole genome and biological characteristics were elucidated. …”

Data_Sheet_2_RETRACTED: vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections.pdf by Yalu Ji (6741050)

“…Due to the ability of phages to kill multidrug-resistant bacteria, the use of phage therapy to combat multidrug-resistant bacterial infections has attracted attention. In this study, a T. pyogenes phage, vB-ApyS-JF1 (JF1), was isolated from sewage samples, and its whole genome and biological characteristics were elucidated. …”

Data_Sheet_1_RETRACTED: vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections.docx by Yalu Ji (6741050)

“…Due to the ability of phages to kill multidrug-resistant bacteria, the use of phage therapy to combat multidrug-resistant bacterial infections has attracted attention. In this study, a T. pyogenes phage, vB-ApyS-JF1 (JF1), was isolated from sewage samples, and its whole genome and biological characteristics were elucidated. …”

PIK3C3 is not involved in the formation of PtdIns(3)P at the inner membrane of protrusions. by Steven J. Rolland (21376879)

Fig 4 - by Sheona Isobel Shankland (19976311)

Macroscopic evaluation of colons. by Leyla Tekin (21492873)

“…The weight loss was remarkably decreased in Group 4, when compared with Group 3, on day 29. e) Disease activity index (DAI) was significantly decreased in Group 3 and Group 4 compared to Group 2 (p < 0.05 and p < 0.05, respectively). …”

The critical role of PROX1 in mesenchymal-endothelial transition induced by KSHV. by Yao Ding (1429924)

Estimated trajectory path for <i>S</i>, <i>V</i>₁, <i>E</i>₁, <i>A</i>₁, <i>I</i>₁, and <i>R</i>₁ for the Delta variant. by Olusegun Michael Otunuga (13175869)

Decision-making deconstructed. by Jyotika Bahuguna (729510)

“…Contours were generated by simulations of the DDM with drift rate <i>v</i> and boundary height <i>a</i> selected on a fine grid of values. …”

Data_Sheet_1_Gut Microbiota Composition Associated With Clostridium difficile-Positive Diarrhea and C. difficile Type in ICU Patients.docx by Juping Duan (4337932)

“…This prospective study aims to use 16S rDNA (and metagenome) sequencing to compare the microbiota composition of 58 (and 5) ICU patients with CDpD (CDpD group), 33 (and 4) ICU patients with C. difficile-negative diarrhea (CDnD group), and 21 (and 5) healthy control subjects (control group), as well as CDpD patients in the A⁺B⁺ (N = 34; A/B: C. difficile TcdA/B), A⁻B⁺ (N = 7), and A⁻B⁻ (N = 17) subgroups. …”

Effect of NAIs exposure on rat skin TGFβ1 and VEGFR-2 expression in the wound healing of four groups of rats. by Yu-Hsuan Cheng (4840704)

Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in recovered COVID-19 individuals by Jian Zhang (1682)

“…</b><b> </b><b>Symptoms of COVID-19 are varied and can be asymptomatic, mild, moderate, and severe</b><b>^5,6</b><b>. In the early phase of SARS-CoV-2 infection, T and B cell counts are dramatically decreased</b><b>^7,8</b><b>; however, IgM</b><b>^9-12</b><b> and IgG</b><b>^13-15</b><b> are detectable within 14 days after symptom onset. …”

Data Sheet 1_Gram-positive enhancer matrix delivering FVpE via M cell targeting elicit protective mucosal and adaptive immune responses against Helicobacter pylori infection.doc by Furui Zhang (3181935)

“…Finally, H. pylori-infected mice treated with GEM-SAM-FVpE can significantly reduce the colonization of H. pylori in gastric tissue while also decreasing gastric mucosal damage.…”

Critical time window for HIFN intervention: Mice received their initial treatment with HIFN (40 mg/kg) at various times relative to blast exposure (treatment time post blast) and w... by Shweta Modgil (12864344)

Cartoon illustrating the test food chain with 24 nm polystyrene nanoparticles added at a concentration of 0.01% (w/v) to an algal culture, which after 24 h was filtered and fed to... by Tommy Cedervall (331814)